<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">Midbrain neurons derived from sporadic patients showed increased susceptibility to the effects of adaptive immune cells
 <sup>
  <xref ref-type="bibr" rid="CR72">72</xref>
 </sup>. Sporadic patient neuronal lines co-cultured with T-lymphocytes exhibited substantial signs of cell death mediated by IL-17â€“IL-17R signaling and activation of NFkB
 <sup>
  <xref ref-type="bibr" rid="CR72">72</xref>
 </sup>. Similarly, IL-17 treatment resulted in increased neuronal death
 <sup>
  <xref ref-type="bibr" rid="CR72">72</xref>
 </sup>. Inflammation in the central nervous system and periphery are key hallmarks of PD
 <sup>
  <xref ref-type="bibr" rid="CR220">220</xref>
 </sup>. Increasing evidence implicates the role of microglia in neuronal loss, though the underlying mechanisms remain to be determined
 <sup>
  <xref ref-type="bibr" rid="CR221">221</xref>,
  <xref ref-type="bibr" rid="CR222">222</xref>
 </sup>. RNA-seq analysis of astrocytes derived from 
 <italic>LRRK2-G2019S</italic> iPSCs highlighted dysregulation in genes involved in the extracellular matrix, which may reduce the neuroprotective capacity of astrocytes in PD
 <sup>
  <xref ref-type="bibr" rid="CR78">78</xref>
 </sup>. Investigating the role of neuroinflammation in patient-derived microglia may also contribute to the understanding of the selective vulnerability of mDA neurons in sporadic and late-onset PD
 <sup>
  <xref ref-type="bibr" rid="CR223">223</xref>
 </sup>.
</p>
